CSIMarket


Charles River Laboratories International inc   (CRL)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Charles River Laboratories International inc

CRL's Fundamental analysis








Looking into Charles River Laboratories International Inc growth rates, revenue grew by 21.52 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 1663

Medical Laboratories industry recorded deterioration of revenues by -1.89 %

Charles River Laboratories International Inc 's net income grew by 35.24 % in IV. Quarter 2022 year on year, above company average,

More on CRL's Growth


Charles River Laboratories International Inc
current PE on trailing twelve month basis is below Medical Laboratories industry average.

Charles River Laboratories International Inc PEG ratio is at 0.83 Charles River Laboratories International Inc realized cash outflow of $ -0.1per share in trailing twelve-month period.
Company
20.93
PE TTM   
Industry
28.78
PE TTM    
Company's Price to Sales ratio is at 2.56.
Medical Laboratories industry's Price to Sales ratio is at 2.14.


More on CRL's Valuation
 
 Total Debt (Millions $) 2,708
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 5.36
 Tangible Book Value (Per Share $) -16.07

Charles River Laboratories International Inc
current PE on trailing twelve month basis is below Medical Laboratories industry average.

Charles River Laboratories International Inc PEG ratio is at 0.83 Charles River Laboratories International Inc realized cash outflow of $ -0.1per share in trailing twelve-month period.
Company
20.93
PE TTM   
Industry
28.78
PE TTM    
Company's Price to Sales ratio is at 2.56.
Medical Laboratories industry's Price to Sales ratio is at 2.14.

Charles River Laboratories International Inc Price to Book Ratio is at 3.42 lower than Indusry Avg. of 360.13. and higher than S&P 500 Avg. of -0.01

More on CRL's Valuation

  Market Capitalization (Millions $) 10,190
  Shares Outstanding (Millions) 51
  Employees -
  Revenues (TTM) (Millions $) 3,976
  Net Income (TTM) (Millions $) 493
  Cash Flow (TTM) (Millions $) -5
  Capital Exp. (TTM) (Millions $) -325
  Total Debt (Millions $) 2,708
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 5.36
  Tangible Book Value (Per Share $) -16.07

  Market Capitalization (Millions $) 10,190
  Shares Outstanding (Millions) 51
  Employees -
  Revenues (TTM) (Millions $) 3,976
  Net Income (TTM) (Millions $) 493
  Cash Flow (TTM) (Millions $) -5
  Capital Exp. (TTM) (Millions $) -325


    CRL's Profitability Comparisons
Charles River Laboratories International Inc faced margin deterioraten, primarily through cost control. Operating Margin fell in IV. Quarter 2022 to 14.89 % from 15.26 % in III. Quarter.

Charles River Laboratories International Inc net profit margin of 17.19 % is currently ranking no. 6 in Medical Laboratories industry, ranking no. 65 in Healthcare sector and number 820 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 1.74
  Total Debt to Equity (MRQ) 0.91
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.53
  Inventory Turnover Ratio (TTM) 8.61



Charles River Laboratories International Inc faced margin deterioraten, primarily through cost control. Operating Margin fell in IV. Quarter 2022 to 14.89 % from 15.26 % in III. Quarter.

Charles River Laboratories International Inc net profit margin of 17.19 % is currently ranking no. 6 in Medical Laboratories industry, ranking no. 65 in Healthcare sector and number 820 in S&P 500.

More on CRL's Key Ratios



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TSVT's Profile

Stock Price

TSVT's Financials

Business Description

Fundamentals

Charts & Quotes

TSVT's News

Suppliers

TSVT's Competitors

Customers & Markets

Economic Indicators

TSVT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071